Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease | BMC Neuroscience | Full Text

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease | BMC Neuroscience | Full Text

Preservation of dopaminergic neurons in a Parkinson's Disease model

Chondroitinase ABC (ChABC) treatment has been found to reduce dopaminergic nigral cell death and striatal terminal loss in a Parkinson's Disease model.